entinostat has been researched along with Lymphoma, Primary Effusion in 1 studies
Lymphoma, Primary Effusion: A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Importantly, in vivo preclinical studies showed that 009P1 and 009P2 dramatically suppressed KSHV+ lymphoma progression with oral bioavailability and minimal visible toxicity." | 1.91 | Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas. ( Chen, J; Chen, Z; Dai, L; Kendrick, S; Li, HY; Lin, Z; Phuc, T; Qin, Z; Wang, Z; Xu, Z; Yang, D, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Wang, Z | 1 |
| Phuc, T | 1 |
| Xu, Z | 1 |
| Yang, D | 1 |
| Chen, Z | 1 |
| Lin, Z | 1 |
| Kendrick, S | 1 |
| Dai, L | 1 |
| Li, HY | 1 |
| Qin, Z | 1 |
1 other study available for entinostat and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; Humans; | 2023 |